Home > Annual Financials > EFC (I)

EFC (I) Financial Statement Analysis
[BOM: 512008|NSE : EFCIL]

The Revenues of EFC (I) have increased by 306.40% YoY .
The Earnings Per Share (EPS) of EFC (I) has decreased by -2.75 % YoY.
COMMUNITY POLL
for EFC (I)
Please provide your vote to see the results

EFC (I) Last 5 Annual Financial Results
[BOM: 512008|NSE : EFCIL]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Operating Income ₹419 Cr₹103 Cr₹0.00 Cr₹0.00 Cr
Operating Expenses ₹91 Cr₹28 Cr₹0.00 Cr₹0.00 Cr
Expenses ₹237 Cr₹48 Cr₹0.09 Cr₹0.09 Cr
Operating Profit (Excl OI) ₹183 Cr₹55 Cr₹-0.09 Cr₹-0.09 Cr
Other Income ₹9.32 Cr₹0.85 Cr₹0.11 Cr₹0.11 Cr
Interest ₹35 Cr₹15 Cr₹0.00 Cr₹0.00 Cr
Depreciation ₹76 Cr₹34 Cr₹0.00 Cr₹0.00 Cr
Profit Before Tax ₹81 Cr₹7.19 Cr₹0.02 Cr₹0.02 Cr
Profit After Tax ₹63 Cr₹3.86 Cr₹0.01 Cr₹0.01 Cr
Consolidated Net Profit ₹58 Cr₹4.34 Cr₹0.01 Cr₹0.01 Cr
Earnings Per Share (Rs)₹11.33₹11.65₹6.35₹0.18
PAT Margin (%)21.4415.093.740.00
ROE(%)29.0325.4710.730.76
ROCE(%)37.3234.5632.821.17
Total Debt/Equity(x)0.430.270.830.00

Key Financials

Market Cap : ₹ 3,020.9 Cr
Revenue (TTM) : ₹ 1,036.7 Cr
Net Profit(TTM) : ₹ 234.7 Cr
EPS (TTM) : ₹ 15.9
P/E (TTM) : 12.9

Industry Peers & Returns1W1M1Y
EFC (I) 10.7% 15.1% -38.6%
SAGILITY 4% 1.8% -1.2%
SYNGENE INTERNATIONAL 1.6% 0.4% -31.9%
PRIME FOCUS 11.1% 4.4% 112.8%
INTERNATIONAL GEMOLOGICAL INSTITUTE 2.6% 0% 0.5%
INDEGENE -1.5% -2% -10.5%
NESCO 3% -3% -0.3%
LATENT VIEW ANALYTICS 0.1% -10.9% -31.6%
SUN PHARMA ADVANCED RESEARCH COMPANY 3.3% 14.9% 49.8%


EFC (I) Revenues
[BOM: 512008|NSE : EFCIL]

Y-o-Y

306.40 %

5 Yr CAGR

0 %

Years Revenues % Change
Mar2025 ₹419 Cr
306.40
Mar2024 ₹103 Cr
0
Mar2023 ₹0.00 Cr
0
Mar2022 ₹0.00 Cr -


EFC (I) Operating Profit
[BOM: 512008|NSE : EFCIL]

Y-o-Y

229.54 %

5 Yr CAGR

Positive

Years Operating Profit % Change
Mar2025 ₹183 Cr
229.54
Mar2024 ₹55 Cr
Positive
Mar2023 ₹-0.09 Cr
Negative
Mar2022 ₹-0.09 Cr -

Operating Margins
Y-o-Y

-18.92 %

5 Yr CAGR

0

Years Operating Margin% % Change
Mar2025 43.53%
-18.92
Mar2024 53.69%
0
Mar2023 0%
0
Mar2022 0% -

EFC (I) Profit After Tax
[BOM: 512008|NSE : EFCIL]

Y-o-Y

1,236.61 %

5 Yr CAGR

1,546.08 %

Years Profit After Tax % Change
Mar2025 ₹58 Cr
1,236.61
Mar2024 ₹4.34 Cr
33,269.23
Mar2023 ₹0.01 Cr
0.00
Mar2022 ₹0.01 Cr -

PAT Margins
Y-o-Y

42.08 %

5 Yr CAGR

0

Years PAT Margin(%) % Change
Mar2025 21.44 %
42.08
Mar2024 15.09 %
303.48
Mar2023 3.74 %
0
Mar2022 0 % -

EFC (I) Earnings Per Share (EPS)
[BOM: 512008|NSE : EFCIL]

Y-o-Y

-2.75 %

5 Yr CAGR

297.79 %

Years EPS % Change
Mar2025 ₹11
-2.75
Mar2024 ₹12
83.46
Mar2023 ₹6.35
3,427.78
Mar2022 ₹0.18 -

EFC (I) Return on Capital Employed (ROCE)
[BOM: 512008|NSE : EFCIL]

Y-o-Y

7.99 %

5 Yr CAGR

217.14 %

Years ROCE % Change
Mar2025 37.32%
7.99
Mar2024 34.56%
5.30
Mar2023 32.82%
2,705.13
Mar2022 1.17% -

EFC (I) Share Price vs Sensex

Current Share Price : ₹204.3
Current MarketCap: ₹ 3,020.9 Cr
Updated EOD on :Jul 03,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
EFC (I)

10.7%

15.1%

-38.6%

SENSEX

0.9%

4.2%

-6%

EFC (I) related INDICES

BSE Indices1W1M1Y
BSE SERVICES 2.2% 9.7% 8.3%
No NSE index found

You may also like the below Video Courses


FAQ about EFC (I) Financials


How the annual revenues of EFC (I) have changed ?

The Revenues of EFC (I) have increased by 306.40% YoY .

How the Earnings per Share (EPS) of EFC (I) have changed?

The Earnings Per Share (EPS) of EFC (I) has decreased by -2.75 % YoY .